RT Journal Article SR Electronic T1 Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP 228 OP 232 DO 10.2967/jnmt.121.261979 VO 50 IS 3 A1 Kumar, Munish A1 Subramanian, Karthikeyan A1 Tanwar, Karan Singh A1 Prabhahar, Arun A1 Divyaveer, Smita A1 Sood, Ashwani A1 Mittal, Bhagwant Rai A1 Sood, Apurva YR 2022 UL http://tech.snmjournals.org/content/50/3/228.abstract AB Surgical resection followed by radioactive iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer. 131I is normally excreted through the kidneys, and treatment of patients with end-stage renal disease on hemodialysis requires special attention to the dose of 131I, the timing of dialysis, and radiation safety. We present a case of end-stage renal disease in a postthyroidectomy patient on hemodialysis who required radioactive iodine ablation, and we review the literature.